Toshiba fills senior VP slot in U.S.

Article

Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which

Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which hadbeen lacking for two years.

Annand will be the highest ranking non-Japanese in the multimodalityimaging vendor's U.S. operations, with responsibility for allmodality products. He fills the role at Tustin, CA-based TAMSthat was left vacant by the departure of Ronald B. Schilling in1991 (SCAN 1/29/92).

The executive comes to TAMS from Toshiba's Australiansubsidiary,where he was general manager of the medical division for fouryears. This division's sales grew 44% during his tenure. Annandhas 30 years' experience in the medical industry, having servedin Australia, Canada and the U.S.

In other Toshiba news, the vendor received Food and Drug Administration510(k) clearance last month for its Flexart 0.5-tesla MRI scanner.

Flexart is based on a high-speed RISC microprocessor and hasan icon-based X-Windows graphical user interface for easier operation.Flexart was introduced at last year's Radiological Society ofNorth America meeting (SCAN 11/17/93). The unit is Toshiba's premiummid-field offering.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.